Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. (Q43605435)

25 November 2017

Decline in haemoglobin A1c values in diabetic patients receiving interferon-alpha and ribavirin for chronic hepatitis C. (English)

1 reference

25 November 2017

1 reference

Greenberg PD

1

1 reference

25 November 2017

Rosman AS

2

1 reference

25 November 2017

Eldeiry LS

3

1 reference

25 November 2017

Naqvi Z

4

1 reference

25 November 2017

Bräu N

5

1 reference

25 November 2017

1 September 2006

1 reference

Journal of Viral Hepatitis

25 November 2017

1 reference

25 November 2017

13

1 reference

25 November 2017

9

1 reference

25 November 2017

613-617

1 reference

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study

25 November 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Histological grading and staging of chronic hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

A falling HbA1c is not necessarily an indicator of improving diabetes control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Inaccurate glycosylated hemoglobin A1C measurements in human immunodeficiency virus-positive patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2006.00729.X

Glycosylated hemoglobin levels in Sudanese sickle cell anemia patients

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.1159/000205546

Identifiers

DOI

10.1111/J.1365-2893.2006.00729.X

1 reference

release_pk5hldge35cwzjfe73cevrf7xa

25 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pk5hldge35cwzjfe73cevrf7xa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference